BenzingaSeptember 22, 2026 at 2:36 AM NYLast Month
Morgan Stanley Upgrades West Pharmaceutical Servs to Overweight, Raises Price Target to $400
Morgan Stanley analyst Kallum Titchmarsh upgrades West Pharmaceutical Servs (NYSE:WST) from Equal-Weight to Overweight and raises the price target from $365 to $400.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
